Abstract:
A core-shell gold nanoparticle containing magnetic nanoparticles is provided to improve image clearness of MRI(magnetic resonance image) as MRI T2 contrast agent, and efficiency of cancer diagnosis, and rapidly kill the cancer cells by using laser pulse, so that diagnosis and treatment of cancer are performed simultaneously. A core-shell gold nanoparticle contains a silica core having diameter of 50-500 nm and a gold nanoshell having diameter of 50-500 nm with magnetic nanoparticles having diameter of 2-30 nm which contains polyalkylene glycol on the surface of nanoparticles and a target-directing ligand linked to the polyalkylene glycol, wherein the magnetic nanoparticle is selected from magnetite(Fe3O4), maghemite(gamma-Fe3O4), cobalt ferrite(CoFe2O4), manganese oxide(MnO), manganese ferrite(MnFe2O4), ion-platinum alloy, cobalt-platinum alloy and cobalt; the target-directing ligand is selected from anti-HER2/neu, folate, aptamer and TAT peptide.
Abstract:
An MRI(magnetic resonance imaging) T1 contrasting agent comprising manganese oxide nanoparticles is provided to enhance image resolution as compared to the conventional T1-weighted image, show cell distribution by improving cell-penetrating ability and minimize side effects. An MRI T1 contrasting agent comprises manganese oxide nanoparticles which are coated by a biocompatible material selected from polyvinylalcohol, polylactide, polyglycolide, poly(lactide-co-glycolide), polyanhydride, polyester, polyetherester, polycaprolactone, polyesteramide, polyacrylate, polyurethane, polyvinyl fluoride, poly(vinyl imidazole), chlorosulphonate polyolefin, polyethylene oxide, poly(ethylene glycol) and dextran, and have particle size of 50 nm or less, preferably 40 nm or less, or more preferably 35 nm or less. Further, a thickness of the poly(ethylene glycol) is 5 to 10 nm.